Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 188

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 188
---
holders. The business address of this stockholder is 1 Het Overloon, 6411 TE Heerlen, Netherlands.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| (6) | Consists of (1) 104,712 Ordinary Shares and warrants to purchase 11,666 Ordinary Shares owned by the Medica III Investments (International) L.P, (2) 38,061 Ordinary Shares and warrants to purchase 4,240 Ordinary Shares owned by Medica III Investments (Israel) LP; (iii) 41,362 Ordinary Shares and warrants to purchase 4,608 Ordinary Shares owned by Medica III Investments (SF) LP; (iv) 22,262 Ordinary shares and warrants to purchase 2,480 Ordinary Shares owned by Medica III Investments (PF) LP; (v) 53,772 Ordinary Shares and warrants to purchase 5,991 Ordinary Shares owned by Medica III Investments Israel (B) LP; (vi) 49,636 Ordinary Shares and warrants to purchase 5,530 Ordinary Shares owned by Poalim Medica III Investments LP. The beneficial owners under Medica Group are: MCP Opportunity Secondary Program III L.P with 10.57% beneficial ownership, NYC Police Pension Fund with 8.8% beneficial ownership, Quantum Partners LDC with 13.2% beneficial ownership, and Migdal Insurance Company Ltd with 8.8% beneficial ownership. None of which include individuals who hold more than 5% interest. Medica III Management L.P., an entity held 50% by Dr. Ehud Geller and 50% by Batsheva Elran, is the managing entity of Medica III Fund. The principal business address of Medica III Investment is 60C Medinat Hayehudim, Herzliya, 4676670, Israel. |

| (7) | Consists of (1) 108,189 Ordinary Shares and warrants to purchase 11,683 Ordinary Shares held by SCP Vitalife Partners II L.P., and (2) 52,186 Ordinary Shares and warrants to purchase 3,902 Ordinary Shares held by SCP Vitalife Partners (Israel) II L.P. Mr. Jeff Dykan. is the general partner of the foregoing entities, and, as such, holds share voting and dispositive power over the shares held by the foregoing entities. The principal business address of SCP Vitalife Partners II L.P., is Messrs. Churchill and Weisman, 5 Great Valley Parkway